Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 6Phase 2 5Phase NA 3Phase EARLY_PHASE1 1Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 24Breast 3Other 2Gastrointestinal 2Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Glioblastoma 82Glioma 65Brain Neoplasms 60Neuroblastoma 14Astrocytoma 14Neoplasms 10Medulloblastoma 9Oligodendroglioma 8Gliosarcoma 8Breast Neoplasms 8Meningioma 7Diffuse Intrinsic Pontine Glioma 7Central Nervous System Neoplasms 7Recurrence 6Neoplasm Metastasis 6Lung Neoplasms 6Ependymoma 6Sarcoma 5Melanoma 5Neuroma, Acoustic 4Lymphoma, Follicular 4Squamous Cell Carcinoma of Head and Neck 3Rhabdoid Tumor 3Prostatic Neoplasms 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Osteosarcoma 3Neurofibromatosis 2 3Colonic Neoplasms 3

Interventions

montelukast 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Endometrial Neoplasms × CNS × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡